Clavicular’s Extreme Supplement Protocol: A 19-Year-Old Pushing the Boundaries of Natty Plus

Clavicular, the 19-year-old looksmaxxer who has surged to internet fame, is running one of the most aggressive supplementation protocols ever documented by someone his age. His willingness to experiment publicly, combined with his rapid physical transformation, has made his stack the most discussed natty plus protocol on the internet. It also raises serious questions about risk tolerance and the influence of social media on young men’s supplementation decisions.

What His Stack Includes

Clavicular’s protocol goes well beyond the standard MK-677 and enclomiphene foundation. He incorporates a range of compounds spanning growth hormone secretagogues, SERMs, SARMs at various dosages, peptides targeting specific growth factors, and a battery of support supplements. The stack is updated frequently based on blood work results and subjective assessment of effects, which demonstrates a level of systematic experimentation that is unusual for someone his age.

The most notable aspect of his approach is the comprehensiveness. Rather than relying on one or two compounds, he has constructed a protocol that targets multiple anabolic and aesthetic pathways simultaneously: testosterone optimization, growth hormone elevation, collagen synthesis enhancement, and targeted fat loss. Each compound serves a specific function within the broader system.

What Makes It Controversial

The controversy is not about any single compound in his stack. It is about the cumulative risk of running this many compounds simultaneously at age 19. The developing male endocrine system is still maturing into the early to mid-twenties. Hormonal interventions during this window carry theoretical risks to the finalization of the HPTA axis, bone growth plate closure, and neurological development that they would not carry in a fully mature adult.

Additionally, when you are running multiple compounds, isolating the cause of any adverse effect becomes extremely difficult. If blood work shows an abnormality, which compound is responsible? If you experience a side effect, which compound do you adjust? The diagnostic complexity scales exponentially with each additional variable in the protocol. This is a direct challenge to the Tony Huge Laws of Biochemistry Physics, which emphasize the non-linear and often unpredictable interactions between multiple active compounds in a biological system.

The Positive Precedent

What Clavicular does well is transparency and monitoring. He shares his blood work, discusses side effects openly, and adjusts his protocol based on objective data rather than subjective feel alone. This is the model that every person using performance-enhancing compounds should follow, regardless of age. The harm reduction value of his documentation is significant, even for those who would not replicate his protocol.

His influence has also brought the natty plus concept to an audience of young men who would otherwise be choosing between completely natural lifting and jumping straight to anabolic steroids. If the alternative to his protocol is not sobriety but uninformed steroid use, then a monitored, non-suppressive protocol, even an aggressive one, may represent a net reduction in harm at the population level.

The debate around Clavicular ultimately reflects the broader tension in the natty plus philosophy: where do you draw the line between informed self-experimentation and reckless behavior? The answer depends entirely on the individual’s risk tolerance, monitoring discipline, and understanding of what they are doing. Age is a relevant factor, but it is not the only one.

Interesting Perspectives

While Clavicular’s protocol is extreme, it provides a unique, real-time case study in polypharmacology for aesthetic enhancement. His approach—layering SARMs, peptides, and SERMs—creates a complex biochemical environment that defies simple prediction. Some biohackers argue this “shotgun” method, while risky, may exploit synergistic effects (like GH secretagogues amplifying the tissue-building effects of SARMs) that single-compound protocols miss. Others point to his age as a potential, paradoxical advantage: a more plastic endocrine and nervous system might adapt to or recover from interventions differently than a settled adult’s. His public documentation also forces a conversation about gatekeeping in health optimization. Is his protocol reckless, or is the criticism rooted in an outdated model of paternalism versus patient-led experimentation? His use of frequent bloodwork sets a new standard for accountability, shifting the debate from “should you” to “if you do, here is the minimally responsible way to monitor it.”